Intended Use
This kit is intended for the in vitro quantitative determination of Cancer Antigen 15-3 (CA15-3) in human serum and plasma. Clinically, it is mainly used for the dynamic monitoring of breast cancer to assist in the assessment of disease progress or monitor the therapeutic effect. CEA and CA15-3 and other cancer markers combined detection can significantly improve the sensitivity of breast cancer detection.
